141 related articles for article (PubMed ID: 29672177)
1. Extended-release drug formulations for the treatment of epilepsy.
Brandt C; May TW
Expert Opin Pharmacother; 2018 Jun; 19(8):843-850. PubMed ID: 29672177
[TBL] [Abstract][Full Text] [Related]
2. New antiepileptic drugs in pediatric epilepsy.
Hwang H; Kim KJ
Brain Dev; 2008 Oct; 30(9):549-55. PubMed ID: 18328657
[TBL] [Abstract][Full Text] [Related]
3. New antiepileptic drugs that are second generation to existing antiepileptic drugs.
Bialer M
Expert Opin Investig Drugs; 2006 Jun; 15(6):637-47. PubMed ID: 16732716
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of new antiepileptic drugs.
Gram L
Epilepsia; 1996; 37 Suppl 6():S12-6. PubMed ID: 8941037
[TBL] [Abstract][Full Text] [Related]
5. Important pharmacokinetic properties of antiepileptic drugs.
Bourgeois BF
Epilepsia; 1995; 36 Suppl 5():S1-7. PubMed ID: 8806398
[TBL] [Abstract][Full Text] [Related]
6. Gabapentin and lamotrigine: novel antiepileptic drugs.
Btaiche IF; Woster PS
Am J Health Syst Pharm; 1995 Jan; 52(1):61-9. PubMed ID: 12879525
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
Johannessen SI; Tomson T
Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacokinetics of newer antiepileptic drugs. Lamotrigine, vigabatrin, gabapentin and oxcarbazepine.
Elwes RD; Binnie CD
Clin Pharmacokinet; 1996 Jun; 30(6):403-15. PubMed ID: 8792055
[TBL] [Abstract][Full Text] [Related]
9. Experience from therapeutic drug monitoring and gender aspects of gabapentin and pregabalin in clinical practice.
Johannessen Landmark C; Beiske G; Baftiu A; Burns ML; Johannessen SI
Seizure; 2015 May; 28():88-91. PubMed ID: 25758302
[TBL] [Abstract][Full Text] [Related]
10. Extended-release antiepileptic drugs: a comparison of pharmacokinetic parameters relative to original immediate-release formulations.
Leppik IE; Hovinga CA
Epilepsia; 2013 Jan; 54(1):28-35. PubMed ID: 23190215
[TBL] [Abstract][Full Text] [Related]
11. Retention rates of new antiepileptic drugs in localization-related epilepsy: a single-center study.
Peltola J; Peltola M; Auvinen A; Raitanen J; Fallah M; Keränen T
Acta Neurol Scand; 2009 Jan; 119(1):55-60. PubMed ID: 18616622
[TBL] [Abstract][Full Text] [Related]
12. The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come?
Perucca E; Johannessen SI
Epileptic Disord; 2003 May; 5 Suppl 1():S17-26. PubMed ID: 12915337
[TBL] [Abstract][Full Text] [Related]
13. New antiepileptic drugs.
Wilson EA; Brodie MJ
Baillieres Clin Neurol; 1996 Dec; 5(4):723-47. PubMed ID: 9068877
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic drug monitoring of gabapentin].
Tribut O; Bentué-Ferrer D; Verdier MC;
Therapie; 2010; 65(1):57-60. PubMed ID: 20205997
[TBL] [Abstract][Full Text] [Related]
15. [New antiepileptic drugs].
Rouvel-Tallec A
Rev Med Interne; 2009 Apr; 30(4):335-9. PubMed ID: 19195742
[TBL] [Abstract][Full Text] [Related]
16. Antiepileptic drugs for the elderly: using the old to focus on the new.
French JA; Chadwick DW
Neurology; 2005 Jun; 64(11):1834-5. PubMed ID: 15955930
[No Abstract] [Full Text] [Related]
17. Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive- extended-release and immediate-release tablets: a randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjects.
Gordi T; Hou E; Kasichayanula S; Berner B
Clin Ther; 2008 May; 30(5):909-16. PubMed ID: 18555937
[TBL] [Abstract][Full Text] [Related]
18. Lamotrigine therapy in elderly patients with epilepsy, bipolar disorder or dementia.
Sajatovic M; Ramsay E; Nanry K; Thompson T
Int J Geriatr Psychiatry; 2007 Oct; 22(10):945-50. PubMed ID: 17326238
[TBL] [Abstract][Full Text] [Related]
19. Novel anticonvulsant drugs.
Stefan H; Feuerstein TJ
Pharmacol Ther; 2007 Jan; 113(1):165-83. PubMed ID: 17030393
[TBL] [Abstract][Full Text] [Related]
20. Newer antiepileptic drugs. Towards an improved risk-benefit ratio.
Patsalos PN; Sander JW
Drug Saf; 1994 Jul; 11(1):37-67. PubMed ID: 7917080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
